Tag Archives: Brazil

WHO Threatens Industry Shut-out on Counterfeit Regulation

By William Looney | Published: May 26, 2010

Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]

Posted in Global | Also tagged generics, IFPMA, india, WHO, World Health Assembly, World Health Organization | Leave a comment

US and Europe At Risk from Substandard Medicines

By Julian Upton | Published: February 25, 2010

Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]

Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged biosimilars, China, counterfeit medicines, developing nations, Emerging Markets, Europe, Indian, Regulatory, substandard medicines, Turkey, US | Leave a comment